Newsroom

AUSTIN, Texas--(BUSINESS WIRE)--Pet Honesty launches Cat Squeezables, a new line of eight lickable purées that delivers targeted health benefits in a format cats naturally love....

PARIS & BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Cyllene Therapeutics (“Cyllene”), formerly known as EG 427, today announced the closing of a €33 million Series C financing round co-led by GordonMD Global Investments® LP (“GordonMD”) and Merck Ventures B.V., an affiliate of Merck KGaA, Darmstadt, Germany, as well as T. Andera Partners SAS, Bpifrance Investissement through its InnoBio 3 Fund, L.P., and Lamond Ventures LLC also participated in the round. Proceeds will advance the clinical developm...

RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI) announced today that it has received a ceiling increase valued at more than $140.5 million for the remaining three years of its existing five-year contract to continue providing comprehensive forensic exploitation support to the U.S. Army Development Command (DEVCOM) Command, Control, Communications, Computers, Cyber, Intelligence, Surveillance and Reconnaissance (C5ISR) Center. With this increase, the total contract value will be...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Europe Growth Strength UCITS ETF 06.07.2026 FTEG.LN IE0009F7UB30 125,002.00 EUR 2,708,874.95 21.671  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 06.07.2026 FGOV LN IE00BKS2X200 83,638.00 GBP 1,237,565.86 17.310  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF - September 06.07.2026 MSEP.LN IE0009DRFET8 50,002.00 USD 1,396,912.63 27.937  ...

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics, Inc. (NASDAQ: TTRX), a clinical-stage biotechnology company developing targeted, non-systemic therapies for inflammatory skin diseases, today announced the completion of a comprehensive interim analysis of its ongoing adaptive Phase 2 clinical trial evaluating GX-03 for the treatment of atopic dermatitis. The multi-week review resulted in the final Stage 2 study design, incorporating data-driven refinements to patient selection, dise...

IRVINE, Calif.--(BUSINESS WIRE)--Retirement & Wealth at Alliant, a division of Alliant Insurance Services, has acquired Retirement Solution Group....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Rising Dividend Achievers UCITS ETF 06.07.2026 RDVY LN IE000K5F6EL4 900,002.00 USD 23,033,191.31 25.592  ...

ABERDEEN, Scotland--(BUSINESS WIRE)--KNOT Offshore Partners LP (NYSE:KNOP) (“The Partnership”) Distribution for 2Q 2026 The Partnership announced today that its Board of Directors has declared a quarterly cash distribution with respect to the quarter ended June 30, 2026, of US$ 0.075 per common unit. This cash distribution will be paid on August 13, 2026, to all unitholders of record as of the close of business on July 27, 2026. This distribution reflects the Partnership’s belief, as outlined o...